Neurocrine Biosciences reported $1.11B in Current Assets for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Acadia Pharmaceuticals ACAD:US $ 645.73M 28.25M
Adamas Pharmaceuticals ADMS:US 115.66M 42.45M
Agios Pharmaceuticals AGIO:US $ 1702.56M 652.55M
Alexion Pharmaceuticals ALXN:US $ 6452.6M 619.6M
Alnylam Pharmaceuticals ALNY:US $ 2725.16M 255.08M
Amgen AMGN:US $ 19099M 2200M
Aptinyx Inc APTX:US $ 133.78M 18.63M
Biogen BIIB:US $ 7183.7M 464.2M
Biomarin Pharmaceutical BMRN:US $ 2357.84M 69.07M
Cytokinetics CYTK:US $ 364.23M 68.89M
Dynavax Technologies DVAX:US $ 583.91M 156.37M
Enanta Pharmaceuticals ENTA:US $ 321.15M 107.06M
Exelixis EXEL:US $ 1593.25M 158.98M
Gilead Sciences GILD:US $ 14498M 1220M
Gw Pharmaceuticals GWPH:US $ 718.73M 10.8M
Halozyme Therapeutics HALO:US $ 999.75M 58.03M
Intercept Pharmaceuticals ICPT:US $ 493.1M 5.54M
Intra Cellular Therapies ITCI:US $ 601.3M 47.8M
Nektar Therapeutics NKTR:US $ 1056.15M 42.9M
Neurocrine Biosciences NBIX:US $ 1110.1M 24.7M
Prothena PRTA:US 409.47M 57.17M
Regeneron Pharmaceuticals REGN:US $ 13337.6M 3282.5M
Rigel Pharmaceuticals RIGL:US $ 184.2M 12.56M
Sarepta Therapeutics SRPT:US $ 2265.22M 6.13M
Teva Pharmaceutical TEVA:IT 12.82B 421M
Ultragenyx Pharmaceutical RARE:US $ 949.49M 121.44M
Vertex Pharmaceuticals VRTX:US $ 8457.51M 81.79M
Xoma XOMA:US $ 87.25M 17M
YTE INCY:US $ 2620.06M 170.09M
Zogenix ZGNX:US $ 416.39M 38.34M